Candesartan Cilexetil in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM Preserved)
NCT00634712 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 734
Last updated 2011-01-25
Summary
A study to evaluate the effect of Atacand on patients with heart failure with preserved left ventricular function
Conditions
- Congestive Heart Failure
Interventions
- DRUG
-
Candesartan
- DRUG
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Dr Salim Yusuf
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1999-06-30
- Primary Completion
- 2003-05-31
- Completion
- 2003-05-31
More Related Trials
-
A Study of CK-1827452 Infusion in Stable Heart Failure
NCT00624442 ·Status: COMPLETED ·Phase: PHASE2
-
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart Failure
NCT01035255 ·Status: TERMINATED ·Phase: PHASE3
-
A Randomized, Double-blind Controlled Study Comparing LCZ696 to Medical Therapy for Comorbidities in HFpEF Patients
NCT03066804 ·Status: COMPLETED ·Phase: PHASE3
-
Impact of Sacubitril/Valsartan on Quality of Life and Mortality of CKD vs Non-CKD in Heart Failure Patients
NCT04218435 ·Status: COMPLETED
-
Evaluation of the Effect of Injectable Neucardin on Cardiac Function and Reversal Ventricular Remodeling in Patients With Chronic Systolic Heart Failure
NCT05949801 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Effects of Sacubitril/Valsartan vs. Enalapril on Aortic Stiffness in Patients With Mild to Moderate HF With Reduced Ejection Fraction
NCT02874794 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Evaluate the Effects of AZD3427 in Patients With Heart Failure
NCT04890548 ·Status: WITHDRAWN ·Phase: PHASE1
-
Carbohydrate Antigen 125-guided Therapy in Heart Failure
NCT02008110 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Tolerability Study of AZD4831 in Patients With Heart Failure.
NCT03756285 ·Status: TERMINATED ·Phase: PHASE2
-
A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
NCT06979362 ·Status: RECRUITING ·Phase: PHASE2
-
A Study to Evaluate the Effects of 4 Weeks Treatment With Subcutaneous Elamipretide on Left Ventricular Function in Subjects With Stable Heart Failure With Preserved Ejection Fraction
NCT02814097 ·Status: COMPLETED ·Phase: PHASE2
-
The Effects of Sacubitril/Valsartan on Cardiac Oxygen Consumption and Efficiency of Cardiac Work in Heart Failure Patients
NCT03300427 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Evaluate the Effects of Oral Administration of Lixivaptan in Patients With Congestive Heart Failure
NCT01055912 ·Status: COMPLETED ·Phase: PHASE2
-
Reverse Remodeling Effects of CDR132L in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction and Cardiac Hypertrophy
NCT05953831 ·Status: WITHDRAWN ·Phase: PHASE2
-
Pulmonary REsistance Modification Under Treatment With Sacubitril/valsartaN in paTients With Heart Failure With Reduced Ejection Fraction
NCT05487261 ·Status: RECRUITING ·Phase: PHASE4
-
Evaluate the Effect of Injectable Neucardin on the Cardiac Function of Subjects With Chronic Systolic Heart Failure
NCT04468529 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of CLR325 in Chronic Stable Heart Failure Patients.
NCT02696967 ·Status: COMPLETED ·Phase: PHASE2
-
Tolerability, Pharmacokinetics and Pharmacodynamics of Six Multiple Rising Dose Regimens of BIA 5-453
NCT02840565 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Sacubitril/Valsartan Therapy on Biomarkers, Myocardial Remodeling and Outcomes.
NCT02887183 ·Status: COMPLETED ·Phase: PHASE4
-
Heart Pressure Assessment Study With Tolvaptan to Treat Congestive Heart Failure
NCT00132886 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Efficacy and Safety of AZD4831 in Participants With Heart Failure With Left Ventricular Ejection Fraction > 40%
NCT04986202 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Multicenter, Randomized, Double-Blind, Placebo Controlled, Efficacy Study on the Effects of Tolvaptan on Left Ventricular Dilatation in Congestive Heart Failure Patients
NCT00043758 ·Status: COMPLETED ·Phase: PHASE2
-
PK/PD Study of Subcutaneous Cenderitide Infusion in CHF Patients
NCT01316432 ·Status: COMPLETED ·Phase: PHASE1
-
Product Design Clinical Performance Study of sc2Wear Furosemide Combination Product
NCT02804282 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Real-world Events of Vericiguat in Patients With Chronic Kidney Disease and Heart Failure
NCT07047547 ·Status: RECRUITING ·Phase: NA